Skip to main content

Syzygium cumini (L.) Skeels improves metabolic and ovarian parameters in female obese rats with malfunctioning hypothalamus-pituitary-gonadal axis



Obesity is a chronic and multifactorial disease characterized by increased adipose tissue. In females, obesity leads to reduced ovulation and lower chances of conception in diseases like polycystic ovary syndrome, making it important to characterize complementary medicine to attenuate such deleterious effects. Therefore, the aim of this study was to assess the effects of a hydroethanolic extract from Syzigium cumini leaves in female reproductive impairments present in the obesity model of neonatal L-monosodium glutamate injection.


Newborn Wistar rats received saline (CTRL) or L-monosodium glutamate 4 mg/g BW (MSG). At 90 days of age, CTRL and some MSG rats received saline, while others received hydroethanolic extract of S. cumini leaves (HESc 500 mg/kg/day, MSG-Syz group) for 30 consecutive days. Estrous cycle was determined by daily vaginal washes. On days 26 and 28 of treatment, oral glucose tolerance test and blood collection were performed for biochemical assessment. At the end, animals were euthanized during estrous phase; blood was collected to measure sex hormones and organs collected for weighing and histological evaluation.


MSG-Syz showed reduced Lee Index, retroperitoneal fat pads and restored gluco-insulin axis. Moreover, HESc treatment reduced serum cholesterol levels when compared to MSG. Treatment with HESc did not restore the oligociclicity observed in obese animals, though MSG-Syz reestablished ovarian follicle health back to CTRL levels, with proliferating primordial follicles – these effects were followed by a decrease on periovarian adipocyte area.


This is the first report to show the reversibility of the reproductive dysfunctions seen in MSG female rats through ethnopharmacological treatment. Moreover, it expands the use of HESc as a prominent tool to treat metabolic and reproductive disorders. Finally, we provide novel evidence that, without a functioning hypothalamus-pituitary-gonads axis, metabolic improvement is ineffective for estrous cyclicity, but critical for ovarian follicle health.


Obesity is a chronic and multifactorial disease whose etiology stems mainly from the imbalance between daily energetic consumption and usage with basal metabolism, although genetic and environmental factors are also involved. According to recent estimates there were 1.9 billion overweight individuals over 17 years old in 2014, representing 39% of the world’s adult population while 42 million children under 5 years of age were overweight or obese in 2013 (for review see [1]). These data gain particular importance especially because obesity enhances cardiovascular risk factors, type II diabetes, neurological diseases, cancer and metabolic disorders [1], as well as fertility and reproductive disorders in females [2].

The ovulatory cycle is maintained by the functional and temporal integration of hypothalamus-pituitary-gonads (HPG) axis. The ovulatory function begins with pulsatile secretion of gonadotropin releasing hormone (GnRH) through the hypothalamus. GnRH stimulates the pituitary to release two important gonadotropic hormones: follicle stimulating hormone (FSH) and luteinizing hormone (LH), which act on granulosa and theca cells in the ovary by stimulating the synthesis of estrogens and androgens, respectively. In obese women, elevated serum levels of insulin and leptin cause disruption of this axis via ovarian and hypothalamic actions of these hormones [3]. Insulin directly stimulates androgen synthesis in the ovaries, acting in synergy with LH to increase the production of androgens in theca cells, being considered a co-gonadotrophin [4]. In turn, leptin stimulates neurons producing kisspeptin, a neuropeptide that enhances GnRH release [5].

High evolutionary conservation of reproductive function between mammals allows a parallel to be drawn between rodents and humans [6]. Rats with obesity induced by high fat diet presented early sexual maturity with greater follicular development, but with an accelerated rate of follicular loss and reduced fertile life. In addition, these animals presented more atretic follicles, suggesting that obesity may stimulate follicular apoptosis [7]. Similar to rodents, clinical and epidemiological investigations have shown that excessive fat accumulation leads to irregular menstrual cycles and infertility [8], while being associated with precocious puberty [9] and polycystic ovary syndrome (PCOS) [10].

Several drugs have been used to treat infertility disorders. Treatment of Wistar rats with clomiphene, an ovulation-inducing drug, improved the number of pups per litter [11]. Additionally, it has been demonstrated in vitro that resveratrol inhibits the production of androgen by ovarian theca cells, being clinically relevant for conditions associated with hyperandrogenism, such as PCOS [12], an endocrine disorder commonly associated with hyperinsulinemia and metabolic syndrome [10]. Likewise, insulin-sensitizing agents have been used to reduce hyperinsulinemia, providing positive impacts on reproductive parameters [13].

In this scenario, it is believed that medicinal plants are important sources of new chemicals with virtuous therapeutic properties and fewer side effects [14]. Syzygium cumini (L.) Skeels (Myrtaceae), is a tree popularly known as jambolan in Brazil, jamun in India, black plum in Europe, among others, whose anti-diabetic effects have been widely studied, especially due to its low toxicity [15]. Studies have indicated that ethyl acetic and methanolic extracts from S. cumini seeds have anti-diabetic properties in rats with streptozotocin-induced diabetes [16]. In addition to reducing glycemia, we showed that a polyphenol-rich extract prepared from S. cumini leaves restored peripheral glucose tolerance while inducing insulin secretion [17]. Of note, we have recently characterized the female L-monosodium glutamate (MSG) obese rat as a novel model to investigate the reproductive repercussions of obesity without interference of HPG axis [18].

Thus, taking into consideration the epidemiological importance of obesity and its repercussions on female reproductive system, in the present study we sought to expand the applicability of a hydroethanolic extract of S. cumini leaves (HESc) to female reproduction disorder induced by the MSG obesity model. Additionally, by using MSG-obese rats, we were also able to assess the individual impact of obesity on reproductive function without a functional HPG axis, shedding new evidence on the inter-regulation of obesity on ovarian function.


Botanical material and hydroethanolic extract preparation

Leaves of S. cumini were collected on the beautiful campus of the Federal University of Maranhão (UFMA) in the city of São Luís, MA - Brazil. A sample of the plant was sent to the Herbarium of Maranhão (MAR) of the Department of Biology of the same University, catalogued under number 4.574. HESc was prepared exactly as described previously [17].

Animals and obesity induction

Female adult Rattus norvegicus, Wistar line, were provided by UFMA animal facility. These females were mated with healthy males and their female pups were then submitted to the process of neonatal obesity induction with MSG as described previously [18]. Briefly, the pups received subcutaneous injections of either MSG (4 g/kg/day) or saline at same volume for 5 consecutive days. All animals were kept in polyethylene cages, lined with Xilana®, with food and water ad libitum, under a light/dark cycle of 12 h, at a temperature of 20 ± 2 °C. Experimental procedure was approved by UFMA Ethics Committee for Animal Use (CEUA) under number 016/13.

Experimental design

Upon birth, neonatal female rats were divided in two groups: a lean group, which received saline injections (Lean, n = 9) and an obese group, which received MSG. At 90 days, adult MSG rats were randomized into two subgroups: MSG obese animals receiving saline (NaCl 0.9% 0.1 mL/100 g/day; MSG group, n = 9), and MSG rats treated with HESc at a concentration previously shown to improve metabolic parameters [18] (500 mg/kg/day; MSG-Syz, n = 9). Lean animals also received saline solution – treatment started at 90 days of age, for 30 consecutive days by daily gavage. Concomitant to treatment, their estrous cycle was determined daily by vaginal washes between 8:00 and 10:00 am. Both animals and their chow were weighted thrice a week. Lee index ( (body weight (g) / nasoanal length (cm)) ∙ 1000) is considered an adiposity index in animals [19] and was verified at the beginning and end of treatment. On the 26th and 28th days of treatment, the animals were fasted for oral glucose tolerance test (OGTT) and blood collection for glycemia, triglyceridemia and total cholesterolemia, respectively. After 30 days of treatments all animals were euthanized in estrous phase using ketamine (70 mg/kg) and xylazine (10 mg/kg) i.p. injection followed by exsanguination while in estrous phase within a maximum period of 7 days. Blood was collected for estradiol, testosterone and LH determination; liver, pancreas, retroperitoneal and visceral fat (which corresponds to periovarian fat), uterus and ovaries were collected and weighed. Ovaries and visceral fat were stored in 4% paraformaldehyde for histological analysis while liver was kept frozen for mensuration of liver fat protocols.

Estrous cycle assessment

Estrous cycle was performed daily, always in the morning between 08:00 and 10:00 am by analysis of vaginal washes as previously described [20]. In this procedure, the predominant cell type in vaginal smears, whether nucleated epithelial cells, cornified cells or leukocytes, was determined. The proportion between these cells was used to determine the phases of estrous cycle in: proestrus, estrus, metaestrus and diestrus. Females were identified as having regular or irregular cycles, as well as prolonged estrus according to previously described criteria [18, 20]. Cycle duration was determined by counting the number of days between one estrus to another [21].

Oral glucose tolerance test

On the 26th day of treatment, all animals were submitted to OGTT. Eight-hour fasting animals were submitted to a small tail cut to verify basal glucose level using a digital glucometer (Accu-Chek Active®; Roche Diagnostic System, Branchburg, NJ, USA). Then, animals were given oral glucose (4 g/kg body weight) by gavage. New blood aliquots were collected at times 15, 30, 60, 120 min after glucose administration.

Serum biochemical and hormonal analysis

At the end of treatment all animals were anesthetized and blood collected through aortic puncture and serum stored at − 20 °C until analysis. Serum triglycerides and total cholesterol were determined by spectrophotometric test kits (Labtest®, Lagoa Nova, MG, Brazil). Blood glucose determination was performed using a digital glucometer and its respective reagent tapes (Accu-Chek Active®; Roche Diagnostic System, Branchburg, NJ, USA). Sexual hormones were extracted from the serum prior to the assay as described previously [18]. Briefly, serum and diethyl ether at 1:5 v/v was mixed. This mixture was centrifuged at 1000 rpm for 3 min to separate the surfaces. The upper layer (ether) was collected and the extraction process repeated in the remaining serum. After two extractions, the tube was brought to a water bath for total ether evaporation. Finally, PBS-0.1% Tween buffer was used to dilute the pellet of extracted sex hormones. Before the analysis, a precision curve was obtained with a coefficient value of r2 > 0.96. All samples were measured on the same run. To determine plasma levels of estradiol and testosterone, commercial kits were used in serum (Roche Diagnostics GmbH, Manheim, Germany).

Liver fat measurement

Both extraction and measurement of liver fat were performed exactly as described before [17].

Ovarian histology

Ovaries were removed, cleaned and fixed in 4% paraformaldehyde for 24 h and stored in 70% ethanol until processing. The right ovary was embedded in paraffin and cut into sections 6 μm thick and stained with hematoxylin-eosin (HE). Only follicles containing an oocyte were considered. The oocyte is around 20–30 μm in diameter; therefore, we analyzed one section at every 6 cuts to ensure a minimum distance of 36 μm, preventing multiple counts of the same ovarian follicle. The follicles were classified as: primordial follicles consisting of a flattened and non-uniform layer of granulosa cells around an oocyte; primary follicles had less than two layers of cuboidal granulosa cells; secondary follicles had an oocyte surrounded by at least two layers of cuboidal granulosa cells, with no visible antrum; antral follicles had an oocyte surrounded by several layers of cuboid granulosa cells and containing one or more antral spaces, cumulus oophorus and theca cell layer [22]. Healthy follicles had no deformation on their granulosa or theca cell layers or pyknotic nuclei within their cells. Atretic follicles were characterized by shrinkage or collapse, presenting granulosa cells with at least two pyknotic nuclei or, if antral, with granulosa cells invading the antrum. One researcher single-blinded to the group performed these histological analyses. For statistical analysis, we divided the total number of each follicle type per ovary by the number of sections analyzed within that same ovary, therefore obtaining a mean number per section in order to avoid any bias regarding ovary size.

Adipocyte histology

Periovarian fat deposits were processed together with the right ovary and stained with HE. At least 55 adipocytes were analyzed from each animal in 2–3 fields. All sections were selected at least 100 μm apart if the required number of fields were not sufficient in a single section. This distance prevented multiple analysis of the same adipocyte [23]. Photomicrographs were taken at a magnification of 200X. The area of adipocytes was calculated using AxionVision (AxioVs40x64 V, Carl Zeiss GmBH Microscopy). Subsequently, we calculated the frequency of adipocytes of similar size within 500 μm2. One researcher single-blinded to the group performed these histological analyses.

Statistical analysis

Results are expressed as mean ± S.E.M and the groups compared to each other by ANOVA, using Tukey as post-test. The differences were significant when p < 0.05. The analyses were performed using the statistical program GraphPad Prism version 7.03.


Obesity onset and liver fat accumulation

HESc administration (500 mg/kg/day) promoted a marked weight reduction during the first 10 days of treatment, followed by stabilization (Fig. 1a). This was confirmed by the comparison of proportional weight gain between CTRL and MSG groups, which showed a trend to increase (9.64 ± 2.72 g and 7.91 ± 3.46 g, respectively), whereas MSG-Syz maintained their weight (− 1.10 ± 2.05 g, p < 0.05; Fig. 1b). Nonetheless, when analyzing the Lee Index, it became evident that HESc treatment restored body mass back to CTRL levels, whereas MSG animals continued to increase (Fig. 1c). As shown in Table 1, MSG-obese animals had significant increase in retroperitoneal and periovarian adipose tissue deposits compared to CTRL. Treatment with HESc reduced retroperitoneal fat deposition by 34.2%, an effect not observed on the periovarian adipose deposit (Table 1). Both reductions in Lee Index and fat deposition were not followed by changes on liver fat levels, probably because obesity induction was not sufficient to increase liver fat accumulation.

Fig. 1
figure 1

Weight gain and Lee Index are decreased by subchronic HESc treatment. Wistar lean (CTRL) and obese (MSG) rats received daily (v) isotonic saline administration, whereas some obese were treated with 500 mg/kg HESc (MSG-Syz), for 30 days. a: Weight gain curve of all groups measured weekly from weaning. b: Percentual delta change of body weight during treatment. c: Lee Index before and after treatment. In A and C values are expressed as mean ± SEM. In B data expressed as median, quartiles and range. n = 7–9 (p < 0.05). a: vs CTRL; b: vs MSG; c: vs MSG-Syz

Table 1 HESc reduces fat accumulation without interfering with hepatic lipid profile of MSG-obese rats

Glucolipid profile and glucose tolerance

MSG rats presented higher fasting blood glucose, with glucose intolerance, whereas MSG-Syz showed a significant reduction on both parameters, reaching levels akin to CTRL (Fig. 2a-c). The same pattern was found on total cholesterol levels (Fig. 2d). Interestingly, no difference was found on both triglycerides levels and TyG Index (Fig. 2e-f), providing evidence that MSG-obese animals were not insulin resistant at the end of the study, despite having other comorbidities associated with metabolic syndrome.

Fig. 2
figure 2

HESc reverses glucose intolerance cholesterol levels in MSG-obese female rats. a: Fasting glycemia measured after 8 h fasting. b After 8 h fasting, all groups received glucose (v.o) 4 g/kg. Glucose was measured at 0, 15, 30, 60 and 120 min by a thin tail cut. c: Area under the curve of OGTT. d and e Total cholesterol and triglycerides measured over fasting. f TyG index as a surrogate of insulin resistance. Formula can be checked on Material and Methods section. Values are expressed as mean ± S.E.M, n = 7–9 (p < 0.05). a: vs CTRL; b: vs MSG; c vs MSG-Syz

Estrous cycle and sexual hormones

Considering the close association between obesity and reproductive dysfunction, estrous cycle was monitored throughout treatment. Figure 3 shows that, regardless of treatment, MSG animals were oligocyclic, unlike the normal cyclic profile observed in CTRL rats (Fig. 3a). The quantitative evaluation of cycles is shown in Fig. 4b. MSG and MSG-Syz groups presented a higher percentage of irregularity (63.89 ± 9.04%, 60.42 ± 5.4%, respectively) than CTRL (21.43 ± 5.99%) – only MSG animals had prolonged estrus. The induction of obesity resulted in longer cycles as well (MSG: 5.67 ± 0.3 days) in relation to control (CTRL: 4.24 ± 0.15 days). Despite the metabolic effects described above, treatment with HESc did not modify the pattern of cyclicity, nor did it reduce the duration of cycles in MSG-Syz (6.66 ± 0.45 days) (Fig. 3c). Hormonal dysregulation is often a cause of oligocyclicity, which led us to assess sex hormones important to the HPG axis. However, no difference was detected between group with regards to any of the hormones measured (Table 2).

Fig. 3
figure 3

HESc does not interfere with estrous cyclicity or duration of MSG-obese rats. Vaginal washes were performed daily for 30 consecutive days. a: Representative estrous cycle of CTRL, MSG and MSG-Syz. b: Percentage of regular, irregular and prolonged estrous in all groups. c Cycle duration measured by number of days between consecutive estrous. Values are expressed as mean ± S.E.M., n = 7–9 (p < 0.05). a: vs CTRL

Fig. 4
figure 4

HESc promoted increased follicular production and restores follicle health in MSG-obese rats. At the end of treatment, the ovaries were removed, cleaned, fixed in 4% paraformaldehyde and submitted to histological material preparation procedure. The follicular rate per section was measured. a: follicles per section of each follicle type. b: number of healthy primary, secondary and antral follicles per section, respectively. Values are expressed as mean ± S.E.M., n = 7–9 (p < 0.05). a: vs CTRL; b: vs MSG; c: vs MSG-Syz

Table 2 Subchronic HESc treatment does not alter sexual hormones of MSG-obese rats

Ovarian morphology

Despite the lack of effects of HESc on cyclicity and sexual hormone levels, it seems plausible that these might not reflect both quality and quantity of ovarian follicle maturation. Therefore, we evaluated ovarian follicular development and differentiation, as well as the amount and quality of each follicle type by light microscopy. As shown in Fig. 4a, MSG-Syz animals had a significant proliferation of primordial follicles, which then reflected on the total follicle number. Surprisingly, HESc treatment was able to improve follicle health both in primary and antral follicles (Fig. 4b). Such findings reinforce the follicular degeneration of MSG rats, while subscribing the beneficial effects that HESc promoted on ovarian morphology.

Periovarian adipocyte histology

To assess whether local adipocyte dysfunction was related to the ovarian recovery seen in MSG-Syz, we analyzed periovarian adipocytes. In addition to obesity and fat accumulation, MSG rats presented adipocyte hypertrophy in their periovarian adipose tissue as revealed by histological analysis when compared to CTRL (Fig. 5a-b). The quantitative histological analysis revealed that the MSG group had adipocytes with higher mean area (2143 ± 151.5 μm2) in contrast with CTRL (1391 ± 126.5 μm2; Fig. 5d). Interestingly, HESc restored the mean adipocyte area of MSG-Syz group to numbers comparable to CTRL (1402 ± 206.0 μm2; Fig. 2c-d), with complete reversal of the hypertrophy observed in MSG rats. In agreement, the frequency distribution of adipocyte area showed that the MSG group curve was shifted to the right, while the MSG-Syz group presented distribution similar to CTRL (Fig. 2e). These data indicate a role for periovarian adipose tissue in regulating ovarian function.

Fig. 5
figure 5

Periovarian adipocyte hypertrophy found in MSG rats is reversed by HESc treatment. Periovarian fat deposits were collected at the end of treatment and processed together with ovaries. These were then stained with HE and visualized under an optical microscope with a 200x magnification. Representative sections of CTRL (a), MSG (b) and MSG-Syz (c). d: Average area of periovarian adipocytes. e: Frequency of distribution of periovarian adipocyte area; the area of at least 55 adipocytes was measured in 2–3 different randomly selected fields. Values are expressed as mean ± S.E.M, n = 7–9. (p < 0.05) a: vs CTRL; b: vs MSG


Female obesity leads to HPG axis disorders, resulting in reduced oocyte quality, endometrial receptivity and infertility [24]. Thus, therapeutic measures of adiposity reduction and improvement of the metabolic profile have shown a positive correlation with recovery of ovarian morphology and reproductive health [25]. At the same time, up until now there was no experimental model to address metabolic dysfunction without contribution of the HPG. In the present study, we have demonstrated that administration of HESc to obese MSG rats reduced total and periovarian adiposity, while restoring serum glucose and cholesterol levels with a relevant effect on glucose tolerance. These metabolic effects resulted in a significant recovery of ovarian follicle atresia, without improvement of estrous cycle, thus providing for the first time evidence that metabolic improvement have a positive impact on intraovarian environment regardless of HPG axis.

We have previously shown that neonatal MSG administration leads to a PCOS-like phenotype in young adult female rats [18]. Additionally, we and others have demonstrated the beneficial effects of HESc on metabolic parameters of obese and diabetic animals [17, 26]. Therefore, MSG-Syz animals displayed improved metabolic features, with reduced body weight, Lee index and fat accumulation. Such effects have been extensively studied and ascribed to the flavonoid content of HESc, specifically to myricetin and quercetin identified on this extract [17, 26, 27]. In a study with onion hydroethanolic extract rich in quercetin, Moon et al. (2013) attributed to this flavonoid the antiobesity effects observed in rats fed a high fat diet, since there was suppression of preadipocyte differentiation and inhibition of adipogenesis via modulation of β-oxidation of fatty acids, thermogenesis and lipid metabolism [28]. In this way, we can suggest that the antiobesity effect observed here is likely due to the flavonoid constituents present in HESc.

HESc displayed an anti-hyperglycaemic effect, reducing glycemia levels by 15% in MSG-Syz rats, bringing it back to CTRL levels. Moreover, HESc completely restored peripheral glucose tolerance. Such antidiabetic effects are in agreement with previous literature on the matter. For instance, Anandharajan et al. (2006) demonstrated that methanolic extract of S. cumini increased the expression of glucose transporter type 4 (GLUT-4) in a PI-3-kinase-dependent manner, promoting the activation of peroxisome proliferator-activated receptor gamma (PPAR-γ) pathway - an effect correlated with increased GLUT-4 transcription and consequent uptake of glucose [29]. This mechanism is of paramount importance to the obesity model under study, since obese MSG rats have a reduced number of GLUT-4 transporters in insulin-sensitive tissues [30]. Added to this, another report showed that the hydroethanolic extract of S. cumini leaves improved superoxide dismutase activity in different tissues of diet-induced obese mice, attributing such therapeutic effect to the antioxidant properties of the extract evaluated [26]. Nonetheless, we have shown that the same extract used on the present study induces insulin secretion both in INS-1E pancreatic β cells and ex vivo islets [17] without significant toxicity in vitro (data not published). Thus, we can corroborate previous literature and infer that the significant improvement of glucose metabolism found on MSG-Syz rats is likely due to the above-mentioned mechanisms.

In addition to the effects on glucose metabolism, administration of HESc to MSG rats resulted in a significant reduction in serum cholesterol levels. The hypolipidemic effect of S. cumini has been evidenced in works carried out with different extracts of the seeds and fruits of this species, which have attributed this action to the inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase enzyme, a key enzyme of biosynthesis cholesterol [31, 32]. Therefore, the marked reduction on cholesterol levels seen in MSG-obese female rats is in agreement with previous literature, providing evidence not only that HESc effects are consistent in both genders but also advocating the use of female animals for preclinical studies of hypolipemiant drugs.

Obesity is commonly associated with dysfunctional HPG axis, causing increase on testosterone and LH levels, mainly due to hyperinsulinemia [4, 33]. In fact, most PCOS models display hyperandrogenism, with increased LH levels [34]. On the other hand, female MSG rats do not follow such pattern, because the neonatal injection of this chemical severely damages the median eminence and arcuate nucleus of hypothalamus, leading to an obese animal with low levels of growth hormone (GH) as well as all of the above mentioned HPG hormones [18, 35, 36]. In fact, we described this model as a cheap and feasible tool to investigate the impacts of metabolic syndrome on female reproduction without the interference of HPG axis [18]. Corroborating our previous data, MSG animals displayed unaltered sex hormones, while MSG-Syz treatment was not sufficient to effectively affect these. This could also explain the lack of effect HESc had on estrous cycle, given that the HPG axis is the main regulator of female cycle. Surprisingly, though, HESc administration improved follicular count with recovery of follicular atresia shown in primary and antral follicles of MSG-Syz animals. While other flavonoid-rich extracts have shown positive effects on metabolic disorders, to the best of our knowledge this is the first description of HESc having a positive impact on ovarian function. Likewise, due to the experimental model used in other studies, most interventions result in recovery of both estrous cycle, HPG axis and ovarian follicle health [37, 38], making this the first report to show a detachment between these features, possibly due to the unique characteristics found on MSG rats. Whether the positive effect of HESc on intraovarian environment is an early outcome that would predict improved reproductive function or an isolated effect without further consequences is yet to be established, being a limitation of the present report.

Periovarian adipose tissue has received increasing attention over the past few years. In fact, Wang et al. [39] recently described the importance of ovary fat pad to reproduction in lean mice. Likewise, several reports relate the hypertrophy of periovarian adipocytes to ovarian dysfunction in different models [40, 41]. Therefore, given the beneficial effect of HESc on ovarian follicle development, we sought to determine whether periovarian fat pad is in some way related to the abovementioned effects. MSG rats once again corroborated previous data, showing hypertrophied periovarian adipocytes, whereas MSG-Syz had adipocytes’ comparable to CTRL. It seems reasonably to suggest that the paracrine effects exerted by periovarian adipocytes are important to the ovarian microenvironment and the positive effect seen on ovarian follicles from MSG-Syz could be related to the reduction on periovarian adipocyte area. Such hypothesis should be further investigated in future works.


As a whole, this work shows for the first time that the hydroethanolic extract of S. cumini leaves produces beneficial effects on the metabolic parameters of female MSG-obese rats, without improving their oligocyclicity. Even so, HESc administration improved ovarian follicle health – an effect in some measure due to reduction of periovarian adipocytes. Not less important, this is the first report to show the PCOS-like features of MSG-obese rats can be at least partially reversed by pharmacological treatment, providing novel evidence that, without a functioning HPG axis, metabolic improvement is ineffective for estrous cyclicity, but critical for follicle health. Future perspectives include longer or earlier treatments, which may result in greater benefits on reproductive parameters of MSG-obese female rats.



Follicle stimulating hormone


Growth hormone


Glucose transporter type 4


Gonadotropin releasing hormone




Hydroethanolic extract of S. cumini leaves






Luteinizing hormone


L-monosodium glutamate


Oral glucose tolerance test


Polycystic ovary syndrome


Peroxisome proliferator-activated receptor gamma


  1. O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  2. Balasubramanian P, Jagannathan L, Mahaley RE, Subramanian M, Gilbreath ET, Mohankumar PS, Mohankumar SM. High fat diet affects reproductive functions in female diet-induced obese and dietary resistant rats. J Neuroendocrinol. 2012;24(5):748–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Watanobe H. Leptin directly acts within the hypothalamus to stimulate gonadotropin-releasing hormone secretion in vivo in rats. J Physiol. 2002;545(Pt 1):255–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wu S, Divall S, Nwaopara A, Radovick S, Wondisford F, Ko C, Wolfe A. Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes. 2014;63(4):1270–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sanchez-Garrido MA, Tena-Sempere M. Metabolic control of puberty: roles of leptin and kisspeptins. Horm Behav. 2013;64(2):187–94.

    Article  CAS  PubMed  Google Scholar 

  6. Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86(5):149 1–12.

    Article  PubMed  Google Scholar 

  7. Wang N, Luo LL, Xu JJ, Xu MY, Zhang XM, Zhou XL, Liu WJ, Fu YC. Obesity accelerates ovarian follicle development and follicle loss in rats. Metabolism. 2014;63(1):94–103.

    Article  CAS  PubMed  Google Scholar 

  8. Pandey S, Pandey S, Maheshwari A, Bhattacharya S. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci. 2010;3(2):62–7.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Adair LS, Gordon-Larsen P. Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health. 2001;91(4):642–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36.

    Article  CAS  PubMed  Google Scholar 

  11. Ugwah-Oguejiofor CJ, Bello SO, Okolo RU, Etuk EU, Ugwah MO, Igbokwe VU. Ficus platyphylla promotes fertility in female Rattus norvegicus Wistar strain: a preliminary study. Reprod Biol Endocrinol. 2011;9:145.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, Duleba AJ. Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway. Endocrinology. 2012;153(8):4019–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. A.a.o. Practice Committee of the American Society for Reproductive Medicine. Electronic address, M. Practice Committee of the American Society for Reproductive, Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril. 2017;108(3):426–41.

    Article  Google Scholar 

  14. Hong L, Guo Z, Huang K, Wei S, Liu B, Meng S, Long C. Ethnobotanical study on medicinal plants used by Maonan people in China. J Ethnobiol Ethnomed. 2015;11:32.

    Article  PubMed  PubMed Central  Google Scholar 

  15. S.d.N. Silva, I.C. Abreu, G.F.C. Silva, R.M. Ribeiro, A.d.S. Lopes, M.d.S.d.S. Cartágenes, S.M.d.F. Freire, A.C.R. Borges, M.O.d.R. Borges. The toxicity evaluation of Syzygium cumini leaves in rodents. Revista Brasileira de Farmacognosia. 2012;22(1):102–108.

  16. Shinde J, Taldone T, Barletta M, Kunaparaju N, Hu B, Kumar S, Placido J, Zito SW. Alpha-glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. Carbohydr Res. 2008;343(7):1278–81.

    Article  CAS  PubMed  Google Scholar 

  17. Sanches JR, Franca LM, Chagas VT, Gaspar RS, Dos Santos KA, Goncalves LM, Sloboda DM, Holloway AC, Dutra RP, Carneiro EM, Cappelli AP, Paes AM. Polyphenol-rich extract of Syzygium cumini leaf dually improves peripheral insulin sensitivity and pancreatic islet function in monosodium L-glutamate-induced obese rats. Front Pharmacol. 2016;7:48.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Gaspar RS, Benevides RO, Fontelles JL, Vale CC, Franca LM, Barros Pde T, Paes AM. Reproductive alterations in hyperinsulinemic but normoandrogenic MSG obese female rats. J Endocrinol. 2016;229(2):61–72.

    Article  CAS  PubMed  Google Scholar 

  19. Bernardis LL, Patterson BD. Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. J Endocrinol. 1968;40(4):527–8.

    Article  CAS  PubMed  Google Scholar 

  20. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol. 2002;62(4A):609–14.

    Article  CAS  PubMed  Google Scholar 

  21. Moore CJ, DeLong NE, Chan KA, Holloway AC, Petrik JJ, Sloboda DM. Perinatal Administration of a Selective Serotonin Reuptake Inhibitor Induces Impairments in reproductive function and follicular dynamics in female rat offspring. Reprod Sci. 2015;22(10):1297–311.

    Article  CAS  PubMed  Google Scholar 

  22. Hirshfield AN, Midgley AR Jr. Morphometric analysis of follicular development in the rat. Biol Reprod. 1978;19(3):597–605.

    Article  CAS  PubMed  Google Scholar 

  23. Parlee SD, Lentz SI, Mori H, MacDougald OA. Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol. 2014;537:93–122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Burggraaff JM, Oosterhuis GJ, Bossuyt PM, van der Veen F, Mol BW. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23(2):324–8.

    Article  PubMed  Google Scholar 

  25. Sharma A, Bahadursingh S, Ramsewak S, Teelucksingh S. Medical and surgical interventions to improve outcomes in obese women planning for pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29(4):565–76.

    Article  PubMed  Google Scholar 

  26. Baldissera G, Sperotto ND, Rosa HT, Henn JG, Peres VF, Moura DJ, Roehrs R, Denardin EL, Dal Lago P, Nunes RB, Saffi J. Effects of crude hydroalcoholic extract of Syzygium cumini (L.) Skeels leaves and continuous aerobic training in rats with diabetes induced by a high-fat diet and low doses of streptozotocin. J Ethnopharmacol. 2016;194:1012–21.

    Article  CAS  PubMed  Google Scholar 

  27. Mahmoud II, Marzouk MS, Moharram FA, El-Gindi MR, Hassan AM. Acylated flavonol glycosides from Eugenia jambolana leaves. Phytochemistry. 2001;58(8):1239–44.

    Article  CAS  PubMed  Google Scholar 

  28. Moon J, Do HJ, Kim OY, Shin MJ. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem Toxicol. 2013;58:347–54.

    Article  CAS  PubMed  Google Scholar 

  29. Anandharajan R, Jaiganesh S, Shankernarayanan NP, Viswakarma RA, Balakrishnan A. In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARgamma in L6 myotubes. Phytomedicine. 2006;13(6):434–41.

    Article  CAS  PubMed  Google Scholar 

  30. de Carvalho Papa P, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci. 2002;71(16):1917–28.

    Article  PubMed  Google Scholar 

  31. Sharma B, Balomajumder C, Roy P. Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol. 2008;46(7):2376–83.

    Article  CAS  PubMed  Google Scholar 

  32. Sharma AK, Bharti S, Goyal S, Arora S, Nepal S, Kishore K, Joshi S, Kumari S, Arya DS. Upregulation of PPARgamma by Aegle marmelos ameliorates insulin resistance and beta-cell dysfunction in high fat diet fed-streptozotocin induced type 2 diabetic rats. Phytother Res. 2011;25(10):1457–65.

    Article  PubMed  Google Scholar 

  33. Newell-Fugate AE, Taibl JN, Clark SG, Alloosh M, Sturek M, Krisher RL. Effects of diet-induced obesity on metabolic parameters and reproductive function in female Ossabaw minipigs. Comp Med. 2014;64(1):44–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Noroozzadeh M, Behboudi-Gandevani S, Zadeh-Vakili A, Ramezani Tehrani F. Hormone-induced rat model of polycystic ovary syndrome: A systematic review. Life Sci. 2017;191:259–72.

    Article  CAS  PubMed  Google Scholar 

  35. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science. 1969;166(3903):386–8.

    Article  CAS  PubMed  Google Scholar 

  36. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164(3880):719–21.

    Article  CAS  PubMed  Google Scholar 

  37. Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu J, Cheng W, Yu C. Quercetin decreases insulin resistance in a polycystic ovary syndrome rat model by improving inflammatory microenvironment. Reprod Sci. 2017;24(5):682–90.

    Article  CAS  PubMed  Google Scholar 

  38. R.K. Rajan, S.S. M, B. Balaji, Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism, Pharm Biol 55(1) (2017) 242–251.

  39. Wang HH, Cui Q, Zhang T, Guo L, Dong MZ, Hou Y, Wang ZB, Shen W, Ma JY, Sun QY. Removal of mouse ovary fat pad affects sex hormones, folliculogenesis and fertility. J Endocrinol. 2017;232(2):155–64.

    Article  CAS  PubMed  Google Scholar 

  40. Rodriguez-Castelan J, Mendez-Tepepa M, Carrillo-Portillo Y, Anaya-Hernandez A, Rodriguez-Antolin J, Zambrano E, Castelan F, Cuevas-Romero E. Hypothyroidism reduces the size of ovarian follicles and promotes hypertrophy of Periovarian fat with infiltration of macrophages in adult rabbits. Biomed Res Int. 2017;2017:3795950.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Kim CM, Yi SJ, Cho IJ, Ku SK. Red-koji fermented red ginseng ameliorates high fat diet-induced metabolic disorders in mice. Nutrients. 2013;5(11):4316–32.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


We are thankful to the support given by staff from the Histology and Experimental Physiology Laboratories at the Federal University of Maranhao.


We are thankful to the Fundação de Amparo à Pesquisa, Desenvolvimento Tecnológico e Inovação do Estado do Maranhão (FAPEMA, Universal grant #01571/16), to Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Finance code 001) and to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for financial assistance and scholarships granted to Benevides, ROA; Gaspar, RS and Fontelles JLL. We are also thankful to the University of Reading for financial assistance granted to Gaspar, RS.

Availability of data and materials

All data is available upon reasonable request to the corresponding author.

Author information

Authors and Affiliations



R.O.A.B. participated in the design of the work, acquisition, analysis and interpretation of data, in addition to writing the manuscript. C.C.V., J.L.L.F., L.M.F. and R.S.G. contributed with the acquisition and analysis of data, as well as the final revision of the manuscript. T.S.T. collaborated with the acquisition of data. S.N.S. assisted in the design of this paper and revised the final version, while A.M.A.P. and R.S.G. equally participated from the design, data analysis, writing and final revision of the manuscript. All authors have read and approved the manuscript. All authors agree to be part of the work and ensure the accuracy and impartiality of the data obtained.

Corresponding author

Correspondence to R. S. Gaspar.

Ethics declarations

Ethics approval and consent to participate


Consent for publication


Competing interests

The authors declare that they have no competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benevides, R.O.A., Vale, C.C., Fontelles, J.L.L. et al. Syzygium cumini (L.) Skeels improves metabolic and ovarian parameters in female obese rats with malfunctioning hypothalamus-pituitary-gonadal axis. J Ovarian Res 12, 13 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Obesity
  • Ovary
  • Syzygium cumini
  • Polycystic ovary syndrome
  • Hyperinsulinemia
  • L-glutamate monosodium